Evolent Health, Inc. (EVH) Fair Value 2026

EVH · Health Information Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.8 /10

32 fundamental signals · 6 models active

Value Trap Risk

LOW (31/100)

Quick Summary — As of 2026-08-27, Evolent Health, Inc. (EVH) trades at $4.59, versus a $10.49 median fair value across its 6 active models — 128.5% above the current price. QOC: 5.8/10. Value Trap Risk: 31/100 (LOW). 6/13 models active.

Key Facts

Ticker
EVH
Price
$4.59
Quality Score
5.8/10
Value Trap Risk
31/100
Models Active
6/13
Last Updated
Strength: CUCE Ensemble suggests +82.8% upside with 12% confidence
Risk: Limited model coverage (6/13) may reduce confidence

Is Evolent Health, Inc. (EVH) Undervalued or Overvalued in 2026?

According to CirclFi’s 6-model valuation engine, Evolent Health, Inc. (EVH) appears undervalued as of : the median of 6 independent fair value estimates is $10.49, 128.5% above the current price of $4.59. Estimates range from $2.66 to $17.20. EVH scores 5.8/10 on fundamental quality and 31/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. EVH’s +128.5% gap is wider than that market norm, and the Health Information Services sector median is +4.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Evolent Health, Inc. Stock in 2026? →

What Fair Value Does Each Model Give EVH?

6 Intrinsic Value Models vs. Current Price ($4.59)

Core Models (Unlocked)
Model Fair Value Upside
Ensemble · Low Conviction
 $8.39 +82.8%
Intrinsic · High Conviction
 $4.83 +5.1%
Intrinsic · High Conviction
 $2.66 -42.0%
Unlock the Full Matrix

Access 3 additional models including PWERM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 6 Models →

Cancel anytime · No contracts · Instant access

What Is EVH's Fair Value Range?

Spread across 6 independent models · $2.66 to $17.20

CirclFi's 6 active models place Evolent Health, Inc. (EVH) between $2.66 and $17.20 per share, a spread of 139% of the median. The median of that range — $10.49 — is the fair value CirclFi publishes for EVH, against a current price of $4.59.

Low · RCMH-DCFHigh · Regime Cross
$2.66median $10.49$17.20
Where the range comes from
Most bearish modelRCMH-DCF$2.66
Most bullish modelRegime Cross-Sectional$17.20
Model agreement5 bullish · 1 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for EVH. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on EVH, not a CirclFi price target. How each model works →

What Is Evolent Health, Inc. (EVH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Evolent Health, Inc. is potentially undervalued at its current price of $4.59. Based on our 13-model framework, Evolent Health, Inc.'s intrinsic value is estimated at a median fair value of $10.49 — representing +128.5% implied upside — with 5 out of 6 active models confirming this thesis. Model dispersion is worth noting: Regime Cross targets $17.20 (+274.8%), versus RCMH-DCF at $2.66 (-42.0%). This +316.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About EVH?

6 of 13 models are currently active for EVH. Of these, 5 models suggest upside while 1 model suggests overvaluation. Taken together, their median fair value for EVH is $10.49 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does EVH Rank in Health Information Services?

Among 55 Health Information Services stocks, EVH ranks #37 by Quality of Company score. CirclFi's QOC score of 5.8/10 evaluates 32 fundamental signals. A score of 5.8 reflects mixed fundamentals.

See all Most Undervalued Health Information Services Stocks →

Evolent Health, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is EVH a Value Trap?

CirclFi's Value Trap algorithm assigns EVH a score of 31/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

6 of 13 models are active for Evolent Health, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Evolent Health, Inc.'s fundamental quality profile registers 5.8/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +316.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every EVH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across EVH's 6 active models, average confidence is 34%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Evolent Health, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Health Information Services Stocks Should You Also Analyze?

11 related Health Information Services stocks with 13-model coverage

OMDAOmada Health, Inc.QOC 5.8AMWLAmerican Well CorporationQOC 5.8SOPHSOPHiA GENETICS SAQOC 5.9CTEVClaritev CorporationQOC 5.6PBSVPharma-Bio Serv, Inc.QOC 5.9ACONAclarion, Inc.QOC 5.1VYNDVynleads, Inc.QOC 4.1OPRXOptimizeRx CorporationQOC 8.3TALKTalkspace IncQOC 7.0DOCSDoximity, Inc.QOC 9.6HQYHealthEquity, Inc.QOC 9.5

Read investment analysis: OMDA · AMWL · SOPH · CTEV · PBSV · ACON · VYND · OPRX · TALK · DOCS · HQY

Which Other Stocks Have a Similar Quality Score to EVH?

6 companies across all industries closest to EVH’s Quality of Company score of 5.8/10.

PLBYPlayboy, Inc.QOC 5.8WOLFWolfspeed, Inc.QOC 5.8INVUInvestview, Inc.QOC 5.8INDOIndonesia Energy Corporation LimitedQOC 5.8MINFT LimitedQOC 5.8NVDANVIDIA CorporationQOC 10.0

Read investment analysis: PLBY · WOLF · INVU · INDO · MI · NVDA

Where Does EVH Sit in CirclFi's Health Information Services Rankings?

EVH is ranked against every other Health Information Services stock CirclFi covers in each of these screens.

See all Health Information Services stocks ranked →

What Else Do Investors Ask About Evolent Health, Inc.’s Valuation?

What is Evolent Health, Inc.'s intrinsic value in 2026?

CirclFi puts Evolent Health, Inc. (EVH)'s intrinsic value at $10.49 — the median of 6 independent model estimates as of 2026-08-27, ranging from $2.66 to $17.20. The Quality of Company score is 5.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is EVH overvalued or undervalued right now?

At $4.59, 5 of 6 active models suggest EVH may be undervalued, while 1 indicate potential overvaluation. The median of all 6 fair value estimates is $10.49, 128.5% above the current price of $4.59 — a consensus view that EVH is undervalued. The assessment depends on which methodology best fits Evolent Health, Inc.'s business model in Health Information Services.

What does a Quality of Company score of 5.8 mean for EVH?

Evolent Health, Inc.'s QOC of 5.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on EVH?

CirclFi analyzes EVH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 6 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on EVH?

Of the 6 models currently active on EVH, Regime Cross-Sectional is the most bullish at $17.20 per share, and RCMH-DCF is the most bearish at $2.66. CirclFi's published fair value for EVH is the median of that range, $10.49, not either extreme. The gap between the two ends equals 139% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is EVH a value trap in 2026?

Evolent Health, Inc.'s Value Trap score is 31/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 6-model valuation engine, Evolent Health, Inc. (EVH) has a median fair value of $10.49 — 128.5% above the current price of $4.59 — as of 2026-08-27.” Source: circlfi.com/stock/EVH/ · Methodology
Primary sources for this EVH valuation
  • Financial statements: Evolent Health, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001628908) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for EVH as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 6 mathematical frameworks give you clarity on EVH.

Unlock All 6 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for EVH Unlock All 6 — $39/mo